HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Ming Yin Selected Research

mesoxalonitrile

12/2019Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys.
9/2010Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Ming Yin Research Topics

Disease

30Neoplasms (Cancer)
06/2020 - 05/2004
9Ischemia
12/2019 - 09/2003
7Liver Diseases (Liver Disease)
09/2021 - 09/2003
7Carcinogenesis
10/2019 - 05/2005
5Fatty Liver
01/2019 - 08/2013
5Mitochondrial Diseases (Mitochondrial Disease)
09/2015 - 09/2003
5Hepatocellular Carcinoma (Hepatoma)
08/2013 - 08/2004
3Acute Kidney Injury (Acute Renal Failure)
05/2022 - 01/2006
3Infections
01/2021 - 09/2015
3COVID-19
01/2021 - 01/2021
3Inflammation (Inflammations)
01/2020 - 09/2015
3Alcoholic Liver Diseases (Alcoholic Liver Disease)
10/2019 - 09/2003
3Hepatitis
08/2013 - 09/2003
3Colonic Neoplasms (Colon Cancer)
05/2011 - 02/2007
3Starvation
04/2011 - 02/2008
3Leukemia
04/2010 - 05/2007
2Fibrosis (Cirrhosis)
05/2022 - 09/2018
2Reperfusion Injury
05/2022 - 12/2019
2Non-alcoholic Fatty Liver Disease
01/2022 - 10/2019
2Insulin Resistance
01/2022 - 05/2013
2B-Cell Lymphoma (Lymphoma, B Cell)
12/2017 - 07/2010
2Hypoxia (Hypoxemia)
09/2010 - 08/2007
2Liver Failure
10/2009 - 09/2003
2Brain Ischemia (Cerebral Ischemia)
08/2007 - 11/2002
1Chronic Renal Insufficiency
05/2022
1Obesity
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
06/2020
1Spinal Cord Injuries (Spinal Cord Injury)
04/2020
1Reinjuries
12/2019

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
12/2019 - 11/2002
6CaspasesIBA
05/2011 - 09/2003
5Pharmaceutical PreparationsIBA
06/2020 - 02/2011
5HMGB1 Protein (HMG1)IBA
01/2020 - 01/2018
5Proteasome InhibitorsIBA
08/2012 - 03/2007
4Proteasome Endopeptidase Complex (Proteasome)IBA
08/2012 - 03/2007
4Small Interfering RNA (siRNA)IBA
08/2012 - 07/2005
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 08/2007
3RNA (Ribonucleic Acid)IBA
01/2021 - 01/2021
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2017 - 10/2004
3Death Domain ReceptorsIBA
11/2014 - 09/2003
3UbiquitinIBA
02/2008 - 03/2007
2Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
05/2022 - 12/2019
2Chloroquine (Aralen)FDA LinkGeneric
05/2022 - 07/2009
2CreatinineIBA
05/2022 - 01/2006
2Sirolimus (Rapamycin)FDA Link
05/2022 - 05/2013
2Urea (Carbamide)FDA LinkGeneric
05/2022 - 12/2019
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
05/2022 - 12/2019
2NitrogenIBA
05/2022 - 12/2019
2Indicators and Reagents (Reagents)IBA
01/2021 - 11/2010
2Peptide Hydrolases (Proteases)FDA Link
06/2020 - 03/2006
2InflammasomesIBA
04/2020 - 09/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2019 - 03/2006
2Caspase 3 (Caspase-3)IBA
12/2019 - 06/2005
2Oxygen (Dioxygen)IBA
12/2019 - 08/2007
2Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA
12/2019 - 09/2010
2mesoxalonitrileIBA
12/2019 - 09/2010
2LipidsIBA
01/2019 - 12/2017
2Protein AggregatesIBA
09/2018 - 02/2007
2Therapeutic UsesIBA
01/2018 - 08/2008
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 04/2017
2InterleukinsIBA
12/2017 - 05/2009
2CytokinesIBA
12/2017 - 05/2009
2Protein Kinases (Protein Kinase)IBA
04/2017 - 01/2014
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2016 - 05/2005
2Caspase 2IBA
09/2015 - 07/2005
2Beclin-1IBA
08/2012 - 05/2011
2Cytochromes c (Cytochrome c)IBA
05/2011 - 06/2005
2Anthocyanins (Anthocyanin)IBA
04/2010 - 05/2007
2cyanidin 3-rutinosideIBA
04/2010 - 05/2007
2Caspase 9IBA
06/2005 - 05/2004
1Collagen Type I (Type I Collagen)IBA
05/2022
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
05/2022
1cyclophilin BIBA
05/2022
1VimentinIBA
05/2022
1EnzymesIBA
05/2022
1Cyclin-Dependent Kinase Inhibitor p16IBA
05/2022
1Fibronectins (Fibronectin)IBA
05/2022
1GalactosidasesIBA
05/2022
1Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
05/2022
1fucose-binding lectinIBA
05/2022
1Hepatitis A Virus Cellular Receptor 1IBA
05/2022
1ImmunosorbentsIBA
05/2022
1Conditioned Culture MediaIBA
05/2022
1Phosphotransferases (Kinase)IBA
05/2022
1Peptides (Polypeptides)IBA
05/2022
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2022
1Transforming Growth Factor beta (TGF-beta)IBA
05/2022
1Collagen Type IV (Type IV Collagen)IBA
05/2022
1Complementary DNA (cDNA)IBA
01/2022
1Viral RNAIBA
01/2021
1Cysteine (L-Cysteine)FDA Link
06/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1DAPIIBA
12/2019
1N- succinimidyl- 5- iodo- 3- pyridinecarboxylic acidIBA
12/2019
1carbonyl 3-chlorophenylhydrazoneIBA
12/2019
1PTEN-induced putative kinaseIBA
12/2019
1enhanced green fluorescent proteinIBA
12/2019
1Red Fluorescent ProteinIBA
12/2019

Therapy/Procedure

14Therapeutics
09/2021 - 05/2004
4Drug Therapy (Chemotherapy)
08/2012 - 01/2007